Typical and Atypical Antipsychotics – The Misleading Dichotomy

@article{FischerBarnicol2008TypicalAA,
  title={Typical and Atypical Antipsychotics – The Misleading Dichotomy},
  author={D. Fischer-Barnicol and S. Lanquillon and E. Haen and P. Z{\"o}fel and H. Koch and M. Dose and H. Klein},
  journal={Neuropsychobiology},
  year={2008},
  volume={57},
  pages={80 - 87}
}
Objectives: (1) To investigate the risk of extrapyramidal motor side effects (EPS) associated with the prescription of different antipsychotics under naturalistic treatment conditions; (2) to test the rationale of the terms ‘typical’ and ‘atypical’ based on EPS rates. Design: Cross-sectional study in the federal state of Bavaria. Setting: 20 psychiatric hospitals in Bavaria. Participants: 6,061 inpatients, aged 18–65 years, with psychotic disorders. Main Outcome Measures: Co-medication with the… Expand
Antipsychotic treatment of schizophrenia: an update.
Atypical Antipsychotic Drugs in the Treatment of Parkinson’s Disease
Atypical antipsychotics for psychosis in adolescents.
Schizophrenia: 1979-2009
...
1
2
3
4
...

References

SHOWING 1-10 OF 52 REFERENCES
Extrapyramidal side effects, tardive dyskinesia, and the concept of atypicality.
  • W. Glazer
  • Medicine, Psychology
  • The Journal of clinical psychiatry
  • 2000
Neuroleptic-induced extrapyramidal symptoms are accompanied by cognitive dysfunction in schizophrenia.
Extrapyramidal side effects are unacceptable
  • J. Kane
  • Medicine
  • European Neuropsychopharmacology
  • 2001
Risperidone versus typical antipsychotic medication for schizophrenia.
...
1
2
3
4
5
...